ATB200/AT2221: Preliminary Ph I/II ATB200-02 Study data

Preliminary data from 9 evaluable patients with Pompe’s disease who previously received enzyme replacement therapy (ERT) in the open-label, international Phase I/II ATB200-02 Study showed that ATB200/...